Allan J. Masterson

665 total citations
11 papers, 554 citations indexed

About

Allan J. Masterson is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Allan J. Masterson has authored 11 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Allan J. Masterson's work include Immunotherapy and Immune Responses (6 papers), T-cell and B-cell Immunology (4 papers) and Hepatitis B Virus Studies (3 papers). Allan J. Masterson is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), T-cell and B-cell Immunology (4 papers) and Hepatitis B Virus Studies (3 papers). Allan J. Masterson collaborates with scholars based in Netherlands, United States and Ireland. Allan J. Masterson's co-authors include Alfons J.M. van den Eertwegh, Rik J. Scheper, Herbert M. Pinedo, Tanja D. de Gruijl, Sinéad M. Lougheed, Claudia C. Sombroek, Hans van Vliet, Anita G.M. Stam, Chris J.L.M. Meijer and Y. Graus and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Allan J. Masterson

11 papers receiving 545 citations

Peers

Allan J. Masterson
Abdo Konur Germany
H Fukushima Japan
Armelle Goubard France
Jeffrey Panella United States
Lakshmi Khandke United States
Ingo Backert Germany
Patrick Haddad France
Yung-Chi Chang Taiwan
Sharon Merims Israel
Zoulikha Amraoui Belgium
Abdo Konur Germany
Allan J. Masterson
Citations per year, relative to Allan J. Masterson Allan J. Masterson (= 1×) peers Abdo Konur

Countries citing papers authored by Allan J. Masterson

Since Specialization
Citations

This map shows the geographic impact of Allan J. Masterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan J. Masterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan J. Masterson more than expected).

Fields of papers citing papers by Allan J. Masterson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan J. Masterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan J. Masterson. The network helps show where Allan J. Masterson may publish in the future.

Co-authorship network of co-authors of Allan J. Masterson

This figure shows the co-authorship network connecting the top 25 collaborators of Allan J. Masterson. A scholar is included among the top collaborators of Allan J. Masterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan J. Masterson. Allan J. Masterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Mohamed, Ateesha F., F. Reed Johnson, Brett Hauber, Bénédicte Lescrauwaet, & Allan J. Masterson. (2012). Physicians’ stated trade-off preferences for chronic hepatitis B treatment outcomes in Germany, France, Spain, Turkey, and Italy. European Journal of Gastroenterology & Hepatology. 24(4). 1–1. 11 indexed citations
2.
Temmink, Olaf H., Michiel de Bruin, Adrianus C. Laan, et al.. (2006). The role of thymidine phosphorylase and uridine phosphorylase in (fluoro)pyrimidine metabolism in peripheral blood mononuclear cells. The International Journal of Biochemistry & Cell Biology. 38(10). 1759–1765. 15 indexed citations
3.
Santegoets, Saskia J., Marco W.J. Schreurs, Allan J. Masterson, et al.. (2006). In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line. Cancer Immunology Immunotherapy. 55(12). 1480–1490. 52 indexed citations
4.
Santegoets, Saskia J., Allan J. Masterson, Sinéad M. Lougheed, et al.. (2006). A CD34+ human cell line model of myeloid dendritic cell differentiation: evidence for a CD14+CD11b+ Langerhans cell precursor. Journal of Leukocyte Biology. 80(6). 1337–1344. 59 indexed citations
5.
Santegoets, Saskia J., Marco W.J. Schreurs, Allan J. Masterson, et al.. (2004). In vitro priming of tumor-specific cytotoxic T lymphocytes from healthy donors using allogeneic dendritic cells derived from the MUTZ-3 cell line (NMDC). Cancer Research. 64. 294–294. 1 indexed citations
6.
Bruin, Michiel de, Godefridus J. Peters, Ruud Oerlemans, et al.. (2004). Sulfasalazine Down-Regulates the Expression of the Angiogenic Factors Platelet-Derived Endothelial Cell Growth Factor/Thymidine Phosphorylase and Interleukin-8 in Human Monocytic-Macrophage THP1 and U937 Cells. Molecular Pharmacology. 66(4). 1054–1060. 15 indexed citations
7.
Vliet, Hans van, Johan W. Molling, Nobusuke Nishi, et al.. (2003). Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells.. PubMed. 63(14). 4101–6. 58 indexed citations
8.
Sombroek, Claudia C., Anita G.M. Stam, Allan J. Masterson, et al.. (2002). Prostanoids Play a Major Role in the Primary Tumor-Induced Inhibition of Dendritic Cell Differentiation. The Journal of Immunology. 168(9). 4333–4343. 168 indexed citations
9.
Masterson, Allan J., Claudia C. Sombroek, Tanja D. de Gruijl, et al.. (2002). MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+precursors. Blood. 100(2). 701–703. 133 indexed citations
10.
Hill, Bridget T., Elizabeth Morán, Chantal Etiévant, et al.. (2000). Low-dose twice-daily fractionated X-irradiation of ovarian tumor cells in vitro generates drug-resistant cells overexpressing two multidrug resistance-associated proteins, P-glycoprotein and MRP1. Anti-Cancer Drugs. 11(3). 193–200. 17 indexed citations
11.
Morán, E, A. Larkin, Allan J. Masterson, et al.. (1997). Co-expression of MDR-associated markers, including P-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42. European Journal of Cancer. 33(4). 652–660. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdo Konur Breakdown of academic impact, for papers by H Fukushima Breakdown of academic impact, for papers by Armelle Goubard Breakdown of academic impact, for papers by Jeffrey Panella Breakdown of academic impact, for papers by Lakshmi Khandke Breakdown of academic impact, for papers by Ingo Backert Breakdown of academic impact, for papers by Patrick Haddad Breakdown of academic impact, for papers by Yung-Chi Chang Breakdown of academic impact, for papers by Sharon Merims Breakdown of academic impact, for papers by Zoulikha Amraoui
Rankless by CCL
2026